StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Stock data | 2024 | Change |
---|---|---|
Price | $8.36 | N/A |
Market Cap | $85.64M | N/A |
Shares Outstanding | 10.25M | N/A |
Employees | 92.00 | N/A |